Illumina (ILMN) Competitors $80.16 +0.79 (+0.99%) As of 11:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, BIO, CRL, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Bio-Rad Laboratories Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking. Do institutionals and insiders hold more shares of ILMN or A? 89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is ILMN or A more profitable? Agilent Technologies has a net margin of 19.27% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.56% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Illumina-27.95% 13.37% 5.49% Agilent Technologies 19.27%25.56%13.47% Which has more risk & volatility, ILMN or A? Illumina has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Does the MarketBeat Community believe in ILMN or A? Illumina received 248 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.03% of users gave Agilent Technologies an outperform vote while only 65.19% of users gave Illumina an outperform vote. CompanyUnderperformOutperformIlluminaOutperform Votes111665.19% Underperform Votes59634.81% Agilent TechnologiesOutperform Votes86871.03% Underperform Votes35428.97% Do analysts rate ILMN or A? Illumina currently has a consensus price target of $128.15, indicating a potential upside of 60.34%. Agilent Technologies has a consensus price target of $143.00, indicating a potential upside of 30.91%. Given Illumina's stronger consensus rating and higher possible upside, equities analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 1 Sell rating(s) 10 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.48Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46 Which has better earnings & valuation, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.34B2.92-$1.22B-$6.07-13.17Agilent Technologies$6.51B4.78$1.29B$4.3525.11 Does the media favor ILMN or A? In the previous week, Agilent Technologies had 11 more articles in the media than Illumina. MarketBeat recorded 39 mentions for Agilent Technologies and 28 mentions for Illumina. Illumina's average media sentiment score of 1.20 beat Agilent Technologies' score of 1.17 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 21 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 25 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAgilent Technologies beats Illumina on 10 of the 19 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.67B$4.30B$5.31B$8.42BDividend YieldN/A0.57%5.21%4.10%P/E Ratio-10.4226.5026.7819.69Price / Sales2.923.75386.97118.34Price / Cash20.7236.2438.2534.62Price / Book5.341.546.744.50Net Income-$1.22B-$84.30M$3.23B$248.32M7 Day Performance-1.16%2.23%1.49%-0.03%1 Month Performance7.54%3.41%11.47%12.72%1 Year Performance-25.54%-23.02%16.57%7.38% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.8026 of 5 stars$80.15+1.0%$128.15+59.9%-26.2%$12.69B$4.34B-10.4411,500Positive NewsAnalyst ForecastAAgilent Technologies4.8471 of 5 stars$112.96-0.7%$143.00+26.6%-29.2%$32.21B$6.53B25.9717,900News CoveragePositive NewsUpcoming EarningsMTDMettler-Toledo International4.4726 of 5 stars$1,157.56+0.0%$1,296.13+12.0%-25.6%$24.06B$3.83B28.5618,000News CoveragePositive NewsAnalyst UpgradeWATWaters3.9687 of 5 stars$356.76-0.8%$390.19+9.4%-1.3%$21.23B$2.98B33.318,200Trending NewsTECHBio-Techne4.8455 of 5 stars$49.17+0.2%$73.44+49.4%-43.6%$7.71B$1.21B49.673,000Positive NewsDividend AnnouncementEx-DividendBIOBio-Rad Laboratories4.8061 of 5 stars$247.54-0.5%$327.40+32.3%-21.1%$6.93B$2.54B-3.818,200Positive NewsCRLCharles River Laboratories International4.907 of 5 stars$140.77-0.1%$172.31+22.4%-39.0%$6.91B$4.02B938.4721,400Positive NewsGap DownBRKRBruker4.9326 of 5 stars$37.76+0.6%$60.10+59.2%-52.3%$5.72B$3.45B49.688,520Dividend AnnouncementAnalyst ForecastPACBPacific Biosciences of California1.6035 of 5 stars$1.03-1.0%$2.34+128.2%-46.4%$307.59M$152.36M-0.63730HBIOHarvard Bioscience3.8291 of 5 stars$0.34-0.9%$3.00+791.0%-90.0%$14.89M$91.40M-1.02490Analyst ForecastHigh Trading VolumeTMOThermo Fisher Scientific4.9939 of 5 stars$412.19+0.0%$607.43+47.4%-32.6%$155.60B$42.90B24.94130,000Trending NewsDividend AnnouncementAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ILMN Stock Free ILMN Stock Alerts